[Inhibition of menstrual uterine motility with four beta-adrenergic drugs (author's transl)].
Effects of the sublingual administration of four beta-adrenoceptor drugs on the uterine motility in 40 normal menstruating women were studied. The drugs and total doses tested were: orciprenaline (40 mg), Partusisten (10 mg), salbutamol (8 mg) and isoxsuprine (40 mg). The uterine and antidiuretic activities were studied before and after administration of each one. All those drugs employed reduced greatly the uterine contractions in all the patients. The cardiovascular side-effects were minimal and well tolerated. It suggested that the adrenergic system has an important role in the control of uterine motility during human menstruation.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000328:Adult; D000420:Albuterol / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects; D005260:Female; D005280:Fenoterol / Q000494:pharmacology; D006801:Humans; D007556:Isoxsuprine / Q000494:pharmacology; D008598:Menstruation; D009921:Metaproterenol / Q000494:pharmacology; D014590:Uterine Contraction / Q000187:drug effects*
D000318:Adrenergic beta-Agonists; D005280:Fenoterol; D009921:Metaproterenol; D000420:Albuterol; D007556:Isoxsuprine
Inhibición de la contractilidad del utero menstrual con cuatro fármacos beta-adrenérgicos.